Skip to content

US Dept of Defense – Breast Cancer Research Program – Clinical Research Extension Award – HT9425-23-BCRP-CREA

Home / Funding Opportunity / US Dept of Defense – Breast Cancer Research Program – Clinical Research Extension Award – HT9425-23-BCRP-CREA

US Dept of Defense – Breast Cancer Research Program – Clinical Research Extension Award – HT9425-23-BCRP-CREA

twitterlinkedin

  • up to USD$5M over 4 years or USD$6M over 4 years for Partnering PI option
  • supports research that extends the data collection, follow-up, and analysis of breast cancer clinical research studies
  • intent is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to limited or early termination of patient follow-up and sample collection and analysis
  • Although not all-inclusive, research proposed under this mechanism may entail a deeper molecular analysis of clinical samples, initiation of new correlative studies, biomarker validation, or continuing clinical follow-up of patients currently/previously enrolled in an open/ongoing or completed clinical trial.
  • PIs are required to include two or more breast cancer advocates on their research team
  • Clinical trials are not allowed
– Letters of Intent due 29 November 2022

You may be also interested in ...